DBV Technologies (DBVT) Income from Non-Controlling Interests (2020 - 2026)
Powered by 
Analysis
DBV Technologies (DBVT) Income from Non-Controlling Interests (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | - |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 63.60 Mn |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | - |
| 10 | DBV Technologies | 5.87 Bn | 5.69 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -100,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Sep 30, 2025 | -359,000.00 |
| Jun 30, 2025 | -200,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 196,000.00 |
| Sep 30, 2024 | -41,000.00 |
| Jun 30, 2024 | 67,000.00 |
| Mar 31, 2024 | -59,000.00 |
| Dec 31, 2023 | -19,000.00 |
| Sep 30, 2023 | 73,000.00 |
| Jun 30, 2023 | -10,000.00 |
| Mar 31, 2023 | -82,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Sep 30, 2022 | 41,000.00 |
| Jun 30, 2022 | 200,000.00 |
| Mar 31, 2022 | 24,000.00 |
| Dec 31, 2021 | 45,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 48,000.00 |